COVID-19 can cause depression through direct biological effects on the brain, not just the stress of being sick. Between 20% and 40% of people develop depressive symptoms in the months following infection, a rate far higher than what’s seen after comparable illnesses. An analysis of 81 million health records found that COVID survivors had a 78% greater risk of receiving a first-time psychiatric or neurological diagnosis compared to people who had the flu.
This isn’t simply a case of pandemic stress taking its toll. The virus triggers specific inflammatory and neurochemical changes that overlap with the same pathways disrupted in major depression.
How the Virus Affects the Brain
SARS-CoV-2 triggers a massive release of inflammatory molecules into the bloodstream, sometimes called a cytokine storm. These molecules don’t stay in the lungs. They destabilize the blood-brain barrier, the protective lining that normally keeps harmful substances out of brain tissue. Once that barrier becomes leaky, inflammatory signals and even infected immune cells can cross into the central nervous system.
Inside the brain, this sets off a chain reaction. Inflammatory molecules activate an enzyme that diverts tryptophan, the raw material your body uses to make serotonin, down a different chemical pathway. Instead of becoming serotonin (a key mood-regulating chemical), tryptophan gets converted into compounds that are actively toxic to neurons. This means COVID simultaneously reduces the brain’s supply of a chemical it needs for stable mood while increasing substances that damage brain cells.
The virus also interacts with ACE2 receptors, which are found throughout the brain. When SARS-CoV-2 binds to these receptors and reduces their function, it can disrupt the production of both serotonin and dopamine. Animal studies show that reduced ACE2 expression leads to impaired serotonin synthesis, behavioral changes, and reduced generation of new brain cells. This receptor disruption provides a second, independent pathway from infection to depression, separate from the inflammatory route.
Structural Brain Changes After Infection
Brain imaging studies have found measurable physical changes in people who had COVID. Serial MRI scans reveal reductions in grey matter thickness and white matter integrity, patterns consistent with neurodegeneration or sustained neuroinflammation. Research has also documented signs of accelerated brain aging during the pandemic, with increased rates of mood-related symptoms corresponding to these structural changes. These aren’t subtle statistical findings. They represent visible differences in brain tissue that align with the depressive symptoms patients report.
COVID Depression vs. Pandemic Stress
The pandemic brought isolation, job loss, grief, and uncertainty, all of which can trigger depression on their own. But the biological evidence makes clear that COVID’s effect on mood goes beyond circumstance. The 78% increased risk of a first psychiatric diagnosis compared to flu patients is especially telling, since both groups experienced serious illness and similar psychosocial stressors. The difference is the virus itself.
That said, the two causes aren’t mutually exclusive. Someone already struggling with loneliness or financial pressure who then gets a severe COVID infection faces both biological and psychological risk factors stacking on top of each other.
Who Is Most at Risk
Not everyone who gets COVID develops depression, and certain factors make it more likely. Women report persistent post-COVID symptoms at higher rates than men. Younger people tend to have somewhat lower risk of prolonged symptoms. People with pre-existing mental health conditions face roughly double the risk of developing post-COVID problems (an odds ratio of 2.12 in one large study). Pre-existing respiratory conditions like asthma carry a similar increase in risk.
Severity of the initial infection matters too. The inflammatory cascade that disrupts mood-regulating brain chemistry is most intense in people with more severe COVID. But even mild infections can lead to persistent symptoms. A study identifying predictors of post-COVID conditions after mild infection found that prior psychological health, respiratory problems, sex, and the variant of the virus were among the strongest predictors.
Depression as Part of Long COVID
For many people, depressive symptoms don’t resolve when the acute infection clears. Among those with long COVID, 22% to 30% report ongoing depression, with some estimates reaching 40%. These symptoms can persist for months or longer, often alongside fatigue, cognitive difficulties (sometimes called brain fog), and anxiety. The overlap is not coincidental: the same neuroinflammatory processes that cause depression also contribute to the cognitive and fatigue symptoms that define long COVID.
A large observational study involving over 280,000 patients noted that interventions focused on reducing the inflammatory process, such as physical reconditioning and mindfulness-based approaches, showed promise for these intertwined symptoms.
Treatment for Post-COVID Depression
Post-COVID depression responds to many of the same treatments used for depression generally, but with some nuances. Standard antidepressants that boost serotonin activity have shown effectiveness. In one Italian study of 60 patients with major depressive episodes following COVID, 92% were treated with this class of medication and saw their depression scores drop by more than half within four weeks.
One medication in this class, fluvoxamine, has drawn particular interest because it has anti-inflammatory properties in addition to its effects on mood. Early research suggests it may help reduce fatigue when given during acute infection, though its benefits for other long COVID symptoms are less clear.
Physical activity, structured rehabilitation, and mindfulness practices also play a role, particularly because they address the inflammatory component that distinguishes post-COVID depression from other forms. If you’re experiencing persistent low mood, loss of interest, or difficulty functioning after a COVID infection, these symptoms have a clear biological basis and are worth bringing up with a healthcare provider rather than waiting for them to resolve on their own.